CDIO (Cardio Diagnostics Holdings) Price-to-Operating-Cash-Flow : (As of May. 13, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Cardio Diagnostics Holdings Price-to-Operating-Cash-Flow?

As of today (2025-05-13), Cardio Diagnostics Holdings's share price is $4.9331. Cardio Diagnostics Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-5.84. Hence, Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

CDIO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.035
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Cardio Diagnostics Holdings's Cash Flow from Operations per share for the three months ended in Dec. 2024 was $-1.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-5.84.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -45.00% per year.

During the past 5 years, Cardio Diagnostics Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was -45.00% per year. The lowest was -45.00% per year. And the median was -45.00% per year.

Cardio Diagnostics Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardio Diagnostics Holdings Price-to-Operating-Cash-Flow Chart

Cardio Diagnostics Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Cardio Diagnostics Holdings Quarterly Data
	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Cardio Diagnostics Holdings Price-to-Operating-Cash-Flow Calculation

Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	4.9331	/	-5.838
	=

Cardio Diagnostics Holdings's Share Price of today is $4.9331.
Cardio Diagnostics Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.84.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Cardio Diagnostics Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cardio Diagnostics Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardio Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardio Diagnostics Holdings Inc (NAS:CDIO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

311 West Superior Street, Suite 444, Chicago, IL, USA, 60654

Website

https://www.cdio.ai

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Executives

Robert Philibert	director, 10 percent owner, officer: Chief Medical Officer	400 N. ABERDEEN, SUITE 900, CHICAGO IL 60642
Timur Dogan	officer: Chief Technology Officer	400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642
Meeshanthini Dogan	director, 10 percent owner, officer: Chief Executive Officer	400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642
Warren Hosseinion	director	C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Elisa V Luqman	officer: Chief Financial Officer	37 HARRISON DRIVE, NORTHPORT NY 11768
Khullani Abdullahi	officer: VP of Revenue and Strategy	400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642
Brandon Sim	director	C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
James Intrater	director	C/O CARDIO DIAGNOSTICS HOLDINGS INC., 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642
Oded Levy	director	C/O CARDIO DIAGNOSTICS HOLDINGS INC., 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642
Stanley K. Lau	director	C/O CARDIO DIAGNOSTICS HOLDINGS INC., 400 N. ABERDEEN ST., SUITE 900, CHICAGO IL 60642
Bd Holding, Inc.	10 percent owner	15 PROSPECT PLACE, IOWA CITY IA 52246
Jonathan Intrater	officer: CEO	223 PALMER STREET, PALMER MA 01069
Allan Liu	director	1600 PARKWOOD CIRCLE, STE 200, ATLANTA GA 30339-2119
Loren Mortman	director	207 EAST 74TH STREET, APARTMENT 10F, NEW YORK NY 10021
Mana Capital Llc	10 percent owner	8 THE GREEN, SUITE A, DOVER DE 19901